Osteoporosis: all 1,675 studies

Page 3 of 17. Open to participants first (211), then studies with results posted, then the rest; newest registration first within each.

• China Health Big DataRecruitingNCT03699228
• Chinese Second Hip Fracture EvaluationRecruitingNCT03461237
• Efficacy of Oral Ibandronate in OsteoporosisRecruitingNCT03186131Phase 2
• Efficacy of Zoledronic Acid in OsteoporosisRecruitingNCT03183557Phase 2
• Randomized Fracture Liaison ServicesEnrolling by invitationNCT03178799
• Multicenter Cohort Study on OsteoporosisRecruitingNCT02958020
• Glucocorticoid-induced Osteoporosis in Patients With Chronic Inflammatory Rheumatic Diseases or PsoriasisRecruitingNCT02719314
• Fragility Fracture Liaison Service and Anti-osteoporosis Medication Monitoring Service StudyRecruitingNCT02635022
• Association Between DXA Results and the Complications, Clinical Courses and Outcomes in Chronic Dialysis PatientsRecruitingNCT02616627
• Changes of Bone Turnover Markers and Bone Mineral Density After Osteoporosis TreatmentRecruitingNCT02156999Phase 4
• A Natural History Study of Bone and Mineral DisordersRecruitingNCT00024804
• A Study of Romosozumab (EVENITY®) in Postmenopausal Women in India With Osteoporosis at a High Risk of Fracture.CompletedNCT06079476Phase 4Results posted
• Multicenter Study in Postmenopausal Women With Osteoporosis, ALVOBONDCompletedNCT05395091Phase 3Results posted
• A Study to Compare Efficacy, PK, PD, Safety and IMM of MB09 to Prolia® [EU-sourced] in Postmenopausal Osteoporosis.CompletedNCT05338086Phase 3Results posted
• A Comparison of Serum and Urine N-telopeptide MarkerCompletedNCT05326815Results posted
• Sickle Cell Disease (SCD) Bone Pain StudyActive, not recruitingNCT05283148Not applicableResults posted
• Mitigation of Major Hip Injury Due to Fall With a Smart BeltCompletedNCT05245097Not applicableResults posted
• Comparative Efficacy and Safety Study of RGB-14-P and Prolia® in Women With Postmenopausal OsteoporosisCompletedNCT05087030Phase 3Results posted
• A Study to Test the Efficacy, Safety and Tolerability of Romosozumab Treatment in Postmenopausal Chinese Women With OsteoporosisCompletedNCT05067335Phase 3Results posted
• Real-world Effectiveness and Cardiovascular Safety Study of Abaloparatide in Postmenopausal WomenCompletedNCT04974723Results posted
• Effect of GLP-1 Receptor Agonists on Trabecular Bone ScoreTerminatedNCT04964388Phase 2Results posted
• A Study to Evaluate the Efficacy, Pharmacodynamics, Safety, and Immunogenicity of FKS518 in Postmenopausal Women With OsteoporosisCompletedNCT04934072Phase 3Results posted
• Exercise Mode and Acute Bone ResorptionCompletedNCT04815824Not applicableResults posted
• A Phase 3 Study to Compare Between CT-P41 and US-licensed Prolia in Postmenopausal Women With OsteoporosisCompletedNCT04757376Phase 3Results posted
• Romosozumab in Women With Chronic SCICompletedNCT04708886Phase 2Results posted
• A Study to Compare SB16 (Proposed Denosumab Biosimilar) to Prolia® in Postmenopausal Women With OsteoporosisCompletedNCT04664959Phase 3Results posted
• MoveStrong at Home: A Feasibility Study of a Model for Remote Delivery of Functional Strength and Balance Training Combined With Nutrition Education for Older Pre-frail Adults.CompletedNCT04663685Not applicableResults posted
• Blackcurrants Modify Gut Microbiota and Reduce Osteoporosis and CVD RiskCompletedNCT04431960Phase 1Results posted
• Study to Evaluate the Pharmacokinetics (PK), Pharmacodynamics (PD), and Usability of Abaloparatide-solid Microstructured Transdermal System (sMTS) in Postmenopausal Women With Low Bone Mineral Density (BMD)CompletedNCT04366726Phase 1Results posted
• Intervention on Osteoporosis and Chronic Kidney Disease-mineral and Bone Disorder (CKD-MBD)TerminatedNCT04271605Not applicableResults posted
• Denosumab (DMAB) Discontinuation And Switching In Glucocorticoid-Induced Osteoporosis (GIOP): A Pilot StudyCompletedNCT04177940Phase 4Results posted
• Abaloparatide Before Total Knee ArthroplastyCompletedNCT04167163Phase 4Results posted
• Alterations of GCF Levels of Sclerostin and DKK-1 in Postmenopausal OsteoporosisCompletedNCT04149405Phase 4Results posted
• Models of Primary Osteoporosis Screening in Male VeteransCompletedNCT04079868Not applicableResults posted
• Efficacy & Safety of Abaloparatide-Solid Microstructured Transdermal System in Postmenopausal Women With OsteoporosisCompletedNCT04064411Phase 3Results posted
• Functional Exercise and Nutrition Education Program for Older AdultsCompletedNCT04037436Not applicableResults posted
• Bone Modeling Effects of Combined Anabolic/Antiresorptive AdministrationCompletedNCT04026256Phase 4Results posted
• Study Investigating PK, PD, Efficacy, Safety, and Immunogenicity of Biosimilar Denosumab (GP2411) in Patients With Postmenopausal OsteoporosisCompletedNCT03974100Phase 3Results posted
• The Effects of 12-months of Denosumab on Bone Density in Prevalent Kidney Transplant RecipientsTerminatedNCT03960554Phase 2Results posted
• Denosumab in Treating Patients With Bone Loss Due to Donor Stem Cell TransplantCompletedNCT03925532Phase 2Results posted
• Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Denosumab (AMG 162) in Japanese Postmenopausal WomenCompletedNCT03822078Phase 1Results posted
• Utilizing Protein During Weight Loss to Impact Physical Function and BoneCompletedNCT03819478Not applicableResults posted
• Averting Complications of Proton Pump Inhibitor Therapy by Effervescent Calcium Magnesium CitrateTerminatedNCT03812380Phase 3Results posted
• Xpede Clinical StudyCompletedNCT03730207Not applicableResults posted
• Early Effects of Abaloparatide on Tissue-Based Indices of Bone Formation and ResorptionCompletedNCT03710889Phase 3Results posted
• Safety and Efficacy of Abaloparatide-SC in Men With Osteoporosis (ATOM)CompletedNCT03512262Phase 3Results posted
• Incidence of HANA Conditions in HIV-infected IndividualsCompletedNCT03483584Results posted
• Therapy of the Skeletal Disease of Type 2 Diabetes With DenosumabTerminatedNCT03457818Phase 2Results posted
• A Comparison of Subject-administered Romosozumab With Healthcare Provider-administered Romosozumab for OsteoporosisCompletedNCT03432533Phase 3Results posted
• Bisphosphonates for Prevention of Post-Denosumab Bone LossCompletedNCT03396315Phase 2Results posted
• Effect of VSL#3 on Bone Mineral Density in Postmenopausal WomenTerminatedNCT03165747Phase 2Results posted
• Safety and Efficiency of Denosumab in Pediatric Subjects With Glucocorticoid-induced OsteoporosisCompletedNCT03164928Phase 3Results posted
• Treatment With Zoledronic Acid Subsequent to Denosumab in OsteoporosisCompletedNCT03087851Phase 4Results posted
• Predictive Value of Bone Turnover Markers During Discontinuation With AlendronateCompletedNCT03051620Results posted
• Effect of Soluble Corn Fiber Supplementation for 1 Year on Bone Metabolism in AdolescentsCompletedNCT02916862Phase 2Results posted
• Bone Health in Aging HIV Infected WomenCompletedNCT02815566Phase 4Results posted
• A Safety and Efficacy Study to Evaluate Romosozumab (AMG 785) in South Korean Women With OsteoporosisCompletedNCT02791516Phase 3Results posted
• Preventing Osteoporosis Using DenosumabCompletedNCT02753283Phase 4Results posted
• Persistence With Prolia® (Denosumab) in Postmenopausal Women With OsteoporosisCompletedNCT02732210Results posted
• A Study of Ibandronate (Boniva) to Evaluate Bone Turnover Markers in Women With Treatment-Naive Postmenopausal OsteoporosisCompletedNCT02598934Phase 4Results posted
• Zoledronic Acid for Osteoporotic Fracture Prevention (ZEST II)CompletedNCT02589600Phase 4Results posted
• PTH And Calcium Responses to Exercise in Older Adults Experiment 2 (PACE Sr. 2)CompletedNCT02580604Not applicableResults posted
• Bone Histomorphometry in Postmenopausal Men and Women With Osteoarthritis Undergoing Total Hip ReplacementCompletedNCT02576652Phase 4Results posted
• Effects of Exoskeleton-Assisted Gait Training on Bone Health and Quality of LifeCompletedNCT02533713Not applicableResults posted
• Transdermal Estrogen in Older Premenopausal Women With Anorexia NervosaCompletedNCT02475265Phase 2Results posted
• New Tools for Assessing Fracture RiskTerminatedNCT02436356Not applicableResults posted
• Longitudinal Effects of Denosumab on Trabecular Bone Score and Femur Strength IndexCompletedNCT02435147Results posted
• Efficacy and Safety of Brand Versus Generic Alendronate for Osteoporosis TreatmentCompletedNCT02371252Phase 4Results posted
• Effect of Atorvastatin on Bone-vascular AxisCompletedNCT02342015Phase 4Results posted
• A Study of 2 Different Formulations of Blosozumab (LY2541546) in Post Menopausal WomenTerminatedNCT02337387Phase 1Results posted
• Prevention of Bone Loss After Acute SCI by Zoledronic AcidCompletedNCT02325414Phase 2Results posted
• 99Tc-MDP in Postmenopausal Women With Differentiated Thyroid Cancer and OsteoporosisCompletedNCT02304757Not applicableResults posted
• A 5-Year Follow-up Study Investigating Factors Associated With Osteoporotic Fracture in Chinese Postmenopausal WomenCompletedNCT02247011Not applicableResults posted
• Effect of Alendronate on Bone in People With Chronic Spinal Cord Injury (SCI) Previously Treated With TeriparatideCompletedNCT02195895Phase 2Results posted
• A Study to Compare the Safety and Efficacy of Romosozumab (AMG 785) Versus Placebo in Men With OsteoporosisCompletedNCT02186171Phase 3Results posted
• Denosumab and Teriparatide Study (DATA-HD and DATA-EX)CompletedNCT02176382Phase 4Results posted
• A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With OsteoporosisCompletedNCT02157948Phase 3Results posted
• Effectiveness of DiscontinuinG bisphosphonatEs Study: R21 Pilot StudyCompletedNCT02139007Phase 4Results posted
• A Study of Blosozumab (LY2541546) in Postmenopausal Female ParticipantsCompletedNCT02109042Phase 1Results posted
• 36-month Special Drug Use Surveillance on Frequency of Bone Fractures With Sodium Risedronate 75 mg TabletsCompletedNCT02106442Results posted
• Special Drug Use Surveillance on Long-term Use of Sodium Risedronate Tablets (Benet 75 mg Tablets) (12-month Treatment Survey)CompletedNCT02089997Results posted
• Prevention of Bone Loss After Pediatric Hematopoietic Cell TransplantationCompletedNCT02074631Phase 2Results posted
• A Phase II/III, Double-blind, Parallel Group Comparative Study of Oral Administration of NE-58095 TabletsCompletedNCT02063854Phase 2/3Results posted
• Tocotrienols and Bone Health of Postmenopausal WomenCompletedNCT02058420Phase 1/2Results posted
• Denosumab for Prevention of Post-Teriparatide Bone Loss in Premenopausal Women With IOPCompletedNCT02049866Phase 2Results posted
• Zoledronic Acid Administration in Acute Spinal Cord InjuryCompletedNCT02042872Phase 4Results posted
• 12 Month Extension Study of the Effect of Teriparatide on Bone in People With Chronic Spinal Cord Injury (SCI)CompletedNCT02025179Phase 2Results posted
• A Randomized Phase 3 Study to Evaluate Two Formulations of Romosozumab in Postmenopausal Women With OsteoporosisCompletedNCT02016716Phase 3Results posted
• Denosumab China Phase III StudyCompletedNCT02014467Phase 3Results posted
• Point-of-care Osteoporosis Diagnostics With Bindex® Pocket Size Instrument and FRAXCompletedNCT01998737Results posted
• Efficacy, Safety and Tolerability of Romosozumab in the Treatment of Japanese Women With Postmenopausal OsteoporosisCompletedNCT01992159Phase 2Results posted
• Dissemination of a Theory-Based Bone Health Program in OnlineCompletedNCT01963169Not applicableResults posted
• The Effects of Estrogen Replacement Therapy in Postmenopausal Women With Hypercalciuria and Low Bone MassTerminatedNCT01928082Phase 2Results posted
• A Direct-to-patient Intervention to Increase Rates of Osteoporosis CareCompletedNCT01907269Not applicableResults posted
• Study of the Long-term Effects of Exercise on Heath Indicators in Older PeopleCompletedNCT01874132Not applicableResults posted
• Evaluation of Outcomes for Quality of Life and Activities of Daily Living for BKP in the Treatment of VCFsCompletedNCT01871519Not applicableResults posted
• Study of Romosozumab (AMG 785) Administered to Healthy Participants and Patients With Stage 4 Renal Impairment or Stage 5 Renal Impairment Requiring HemodialysisCompletedNCT01833754Phase 1Results posted
• Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076)TerminatedNCT01803607Phase 3Results posted
• An Open-label Study to Evaluate the Effect of Treatment With Romosozumab or Teriparatide in Postmenopausal WomenCompletedNCT01796301Phase 3Results posted
• Post Marketing Surveillance For General Drug Use To Assess the Safety And Efficacy Profile Of Viviant In Usual PracticeCompletedNCT01793142Results posted

← Osteoporosis overview